Meta acquisition of within reportedly approved by court in loss for ftc

The FTC sued to block Meta's acquisition of Within in July, arguing Meta was using the deal "to buy its way to the top," rather than compete on the me...

February 1, 2023, 1:42 pm

Altria tops earnings estimates for q4, board approves $1 billion share buyback program

Altria Group Inc. MO, +1.21% said Wednesday it had net income of $2.690 billion, or $1.50 a share, in the fourth quarter, up from $1.624 billion, or 8...

February 1, 2023, 7:13 am

Cash flow can make or break a small to mid-sized business. alternative funding sources can help

In fact, 38% of businesses with revenue less than $5 million are approved for bank loans and the latest...

February 1, 2023, 6:44 am

Icymi - spain to raise minimum wage by 8%

Spain was in the news on Monday:

• ...

  February 1, 2023, 3:20 am

Uk mortgage approvals: 35.612k (forecast 45k, previous 46.075k)

UK Mortgage Approvals: 35.612k (Forecast 45k, Previous 46.075k)

...

January 31, 2023, 9:32 am

13 easiest personal loans to get approved for in 2023

We may receive a referral fee from some of the lenders featured in this article. This doesn’t affect our opinions or evaluations Finding … Read Fu...

January 31, 2023, 12:29 am

Woodward increases dividend by 16 percent

FORT COLLINS, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ: WWD) today announced that its Board of Directors...

January 30, 2023, 9:15 pm

Gns stock alert: what to know about the entrepreneur resorts spinoff

Genius Group (NYSEMKT: GNS ) stock is up roughly 40% today following the company's announcement that its board has...

January 30, 2023, 3:10 pm

Jetblue pilots approve contract extension that comes with over 21% in raises

JetBlue pilots' approval comes weeks after Spirit pilots approved a new contract ahead of the airlines'...

January 30, 2023, 2:41 pm

Why genius group shares are trading higher today

Genius Group GNS shares are trading higher after the company's board approved the spinoff of its Entr...

January 30, 2023, 2:04 pm

Approval for anavex's blarcamesine looks inevitable after biogen's leqembi approved

FDA grants emergency approval of Biogen/Eisai's Leqembi (previously Lecanemab), based solely on Phase 2 trial results; Phase 3 results to be considere...

January 30, 2023, 12:13 pm

Tkb critical technologies 1 shareholders approve extension, keeping $55 million in the trust account

EL SEGUNDO, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) — TKB Critical Technologies 1 (“TKB” or the “Company”)(Nasdaq: USCTU, USCT, USCTW), annou...

January 30, 2023, 12:00 pm

Dupixent® (dupilumab) approved by european commission as the first and only targeted medicine indicated for eosinophilic esophagitis

Approximately 60% of patients aged 12 years and older treated with Dupixent 300 mg weekly in the pivotal trial experienced histological disease remiss...

January 30, 2023, 6:00 am

Could this vaccine become sanofi's latest blockbuster?

This vaccine candidate could be approved in newborns and infants later this year....

January 29, 2023, 8:45 am

: house approves bill limiting spr drawdowns, but measure faces long odds in senate

The House of Representatives on Friday approved a bill that would limit drawdowns from the Strategic Pe...

January 27, 2023, 6:05 pm

Why is mullen (muln) stock heating up today?

Investors in Mullen Automotive (NASDAQ: MULN ) are seeing some impressive price action building today. Shares of MULN stock are now up more than 5% ...

January 27, 2023, 1:57 pm

Nexstar media says board is raising quarterly dividend by 50% to $1.35 a share

Nexstar Media Group Inc. NXST, +2.23% said Friday its board has approved a 50% increase in its quarterl...

January 27, 2023, 8:05 am

Dupixent® (dupilumab) recommended for expanded eu approval by the chmp to treat children as young as six months old with severe atopic dermatitis

If approved, Dupixent would be the first and only targeted medicine in the EU for these young children ...

January 27, 2023, 5:59 am

Bioaegis therapeutics announces fda clearance of ind for its ‘inflammation regulator protein,’ gelsolin, for the treatment of ards

NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) — BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory ...

January 26, 2023, 7:05 pm

Zinc8 energy solutions gets us$9m tax credit to build its first production facility in new york state; ceo applauds gov hochul

Zinc8 Energy Solutions (CSE:ZAIR) Inc announced that a grant of up to US$9 million in tax credits from New York State has been...

January 26, 2023, 1:29 pm